Nicki Thompson talks with BiotechTV at BioTrinity 2025

Nicki Thompson, TRIMTECH Therapeutics Limited’s CEO, gave an oral presentation at BioTrinity 2025.  In this post from BiotechTV she reviews the unique properties of TRIM21 that make it so powerful for selectively degrading protein aggregates while leaving soluble protein unaffected.

https://www.linkedin.com/feed/update/urn:li:activity:7313569542482399232